Erica Schleifman
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 20
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 11
-
- Lung Cancer Treatments and Mutations 10
-
- RNA Interference and Gene Delivery 7
- Advanced biosensing and bioanalysis techniques 5
- Molecular Biology Techniques and Applications 3
-
- Lymphoma Diagnosis and Treatment 4
-
- Virus-based gene therapy research 3
- Co-authors
- Peter M. GlazerW. Mark SaltzmanNicole McNeerDavid S. ShamesJoanna ChinDavid FabrizioRachel J. FieldsPriti Kumar
- Partner nations
- United StatesHong KongSwitzerland
In The Last Decade
Erica Schleifman
34 papers receiving 866 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 296
- Oncology 427
- Pulmonary and Respiratory Medicine 310
- Molecular Biology 387
- Immunology 90
Countries citing papers authored by Erica Schleifman
This map shows the geographic impact of Erica Schleifman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica Schleifman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica Schleifman more than expected).
Fields of papers citing papers by Erica Schleifman
This network shows the impact of papers produced by Erica Schleifman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica Schleifman. The network helps show where Erica Schleifman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erica Schleifman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 111 | |
| 4 | 2018 | 47 | |
| 5 | 2017 | 14 | |
| 6 | 2017 | 12 | |
| 7 | 2017 | 62 | |
| 8 | 2016 | 2 | |
| 9 | 2016 | 25 | |
| 10 | 2014 | 21 | |
| 11 | 2014 | 12 | |
| 12 | 2014 | 30 | |
| 13 | 2013 | 3 | |
| 14 | 2013 | 35 | |
| 15 | 2012 | 68 | |
| 16 | 2011 | 47 | |
| 17 | 2011 | 13 | |
| 18 | 2010 | 81 | |
| 19 | 2008 | 20 | |
| 20 | 2008 | 49 |
About Erica Schleifman
Erica Schleifman is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 878 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (20 papers), Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (10 papers), RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Virus-based gene therapy research (3 papers) and Molecular Biology Techniques and Applications (3 papers). The work is most often cited by research in Cancer Research (296 citations), Oncology (427 citations) and Pulmonary and Respiratory Medicine (310 citations). Erica Schleifman has collaborated with scholars based in United States, Hong Kong and Switzerland. Frequent co-authors include Peter M. Glazer, W. Mark Saltzman, Nicole McNeer, David S. Shames, Joanna Chin, David Fabrizio, Rachel J. Fields, Priti Kumar, Leonard D. Shultz and Dale L. Greiner. Their work appears in journals such as Annals of Oncology, Cancer Research, PLoS ONE, Journal of Thoracic Oncology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.